Itraconazole 정맥주사로 빠르게 치료된 Scedosporium apiospermum 에 의한 원발성 피부감염증 1예
Primary Cutaneous Infection with Scedosporium apiospermum Successfully Treated with Intravenouse Itraconazole
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Scedosporium apiospermum is a rising opportunistic fungus that may infect immunocompetent individuals and may cause often fatal disease among the increasing immunosuppressed patient population. This pathogen is typically difficult to treat because of its particular resistance to commonly used antimycotic drugs. We describe an 83-year-old male patient with a history of long-term corticosteroid treatment for chronic prurigo simplex, who developed multiple suppurative nodules on a erythematous plaque at the right forearm. Histological examinations revealed granulomatous infiltration with hyphae and spores in dermis and fungal cultured isolation for definitive diagnosis showed S. apiospermum. Treatment was started with oral fluconazole, but skin lesions were getting worse. Then patient was treated with 200 mg of intravenouse itraconazole daily. Skin lesions showed a marked improvement after 1 week, and completely healing after 3 weeks.
Abstract
Scedosporium apiospermum is a rising opportunistic fungus that may infect immunocompetent individuals and may cause often fatal disease among the increasing immunosuppressed patient population. This pathogen is typically difficult to treat because of its particular resistance to commonly used antimycotic drugs. We describe an 83-year-old male patient with a history of long-term corticosteroid treatment for chronic prurigo simplex, who developed multiple suppurative nodules on a erythematous plaque at the right forearm. Histological examinations revealed granulomatous infiltration with hyphae and spores in dermis and fungal cultured isolation for definitive diagnosis showed S. apiospermum. Treatment was started with oral fluconazole, but skin lesions were getting worse. Then patient was treated with 200 mg of intravenouse itraconazole daily. Skin lesions showed a marked improvement after 1 week, and completely healing after 3 weeks.
참고문헌 (14)
- Dupont B, "Aspects épidémiologiques et cliniques des infections à Scedosporium et à Pseudallescheria", Journal de Mycologie Médicale, 1, pp.33~42 (1991)
- 임 명, "Scedosporium apiospermum에 의한 국소 피부감염증 1예", 대한피부과학회지, 42(11), pp.1505~1507 (2004), 대한피부과학회
- Rippon JW, "Pseudallescheriasis. In: Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes. 3rd ed", pp.651~680 (1988), WB Saunders C
- Kwon-Chung KJ, "Medical mycology", pp.678~694 (1992), Lea & Febiger
- Capilla J, "Correlation between in vitro susceptibility to voriconazole and in vivo outcome of scedosporiosis in guinea pigs", Antimicrob Agents Chemother, 48, pp.4009~4011 (2004)
- Josep GA, "Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist", Medical Mycology, 44, pp.295~327 (2006)
- 정용근, "Voriconazole로 치료한 Scedosporium apiospermum 에 의한 피부감염증 1예", 대한의진균학회지, 13(4), pp.187~191 (2008), 대한의진균학회1
- Karaarslan A, "Skin infection caused by Scedosporium apiospermum", Mycoses, 46, pp.524~526 (2003)
- Miyamoto T, "Scedosporium apiospermum skin infection: a case report and review of the literature", J Am Acad Dermatol, 39, pp.498~500 (1998)
- Torok L, "Scedosporium apiospermum infection imitating lymphocutaneous sporotrichosis in a patient with myeloblastic-monocytic leukemia", Br J Dermatol, 133, pp.805~809 (1995)
- Jingsi Z, "Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents", ippon Ishinkin Gakkai Zasshi, 45, pp.101~104 (2004)
- Lee HJ, "A Case of Cutaneous Abscess Due to Scedosporium apiospermum", Korean J Dermatol, 39, pp.812~815 (2001)
- 최윤림, "Scedosporium apiospermum 피부 감염증 1예", 대한피부과학회지, 43(5), pp.704~706 (2005), 대한피부과학회
- De Beule, "Van Gestel, Jef. Pharmacology of Itraconazole", Drugs, 61, pp.27~37 (2001)